Overview
- 95 inspections across 72 sites are on record.
- 373 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-09-27.
At a glance
Inspections
95
Sites
72
Observations
373
Career since
May 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Fisiopharma Srl | 27 Sep 2019 | Human Drugs | View 483 → |
| Glaxo Operations UK Ltd | 17 Sep 2019 | Human Drugs | View 483 → |
| Pharmco Products Inc. | 21 May 2015 | Human Drugs | On file |
| Cardinal Health 414 LLC | 8 May 2015 | Human Drugs | View 483 → |
| Brookfield Medical/Surgical Supplies, Inc. | 9 Apr 2015 | Human Drugs | View 483 → |
Sites inspected
Fisiopharma SrlPalomonte, Italy1 insp.
Glaxo Operations UK LtdBarnard Castle, United Kingdom1 insp.
Pharmco Products Inc.Brookfield, United States1 insp.
Cardinal Health 414 LLCEast Hartford, United States1 insp.
Brookfield Medical/Surgical Supplies, Inc.Brookfield, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Meisha A Mandal7 shared
Rebecca B Welch6 shared
Edmund F Mrak4 shared
Mark R Mcclain4 shared
Nealie C Newberger3 shared
Diane C Thibodeau3 shared
Jeffrey J Thibodeau3 shared
Janete F Guardia3 shared
Ramon E Martinez2 shared
Simone E Pitts2 shared
Full investigator report
Get the verbatim findings behind Maya M Davis' 373 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site